A detailed history of Nuveen Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 16,544,547 shares of MRK stock, worth $2.05 Billion. This represents 0.66% of its overall portfolio holdings.

Number of Shares
16,544,547
Previous 16,702,700 0.95%
Holding current value
$2.05 Billion
Previous $1.82 Billion 19.89%
% of portfolio
0.66%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $17.9 Million - $20.9 Million
-158,153 Reduced 0.95%
16,544,547 $2.18 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $4.79 Million - $5.21 Million
47,790 Added 0.29%
16,702,700 $1.82 Billion
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $891,135 - $989,640
8,656 Added 0.05%
16,654,910 $1.71 Billion
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $30 Million - $32.7 Million
275,823 Added 1.68%
16,646,254 $1.92 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $9.26 Million - $10.3 Million
89,910 Added 0.55%
16,370,431 $1.74 Billion
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $285 Million - $366 Million
3,262,048 Added 25.06%
16,280,521 $1.81 Billion
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $45.6 Million - $51.3 Million
-539,761 Reduced 3.98%
13,018,473 $1.12 Billion
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $287 Million - $325 Million
3,437,895 Added 33.97%
13,558,234 $1.24 Billion
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $132 Million - $147 Million
-1,789,272 Reduced 15.02%
10,120,339 $800 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $35.7 Million - $44.7 Million
-493,511 Reduced 3.98%
11,909,611 $913 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $143 Million - $157 Million
-1,994,057 Reduced 13.85%
12,403,122 $932 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $378 Million - $418 Million
-5,380,403 Reduced 27.2%
14,397,179 $1.12 Billion
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $297 Million - $349 Million
-4,306,735 Reduced 17.88%
19,777,582 $1.52 Billion
Q4 2020

May 17, 2021

SELL
$71.77 - $79.65 $12 Million - $13.4 Million
-167,648 Reduced 0.69%
24,084,317 $1.97 Billion
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $295 Million - $328 Million
4,112,158 Added 20.42%
24,251,965 $1.98 Billion
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $213 Million - $241 Million
2,907,982 Added 16.88%
20,139,807 $1.67 Billion
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $335 Million - $382 Million
-4,761,907 Reduced 21.65%
17,231,825 $1.33 Billion
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $224 Million - $311 Million
-3,536,414 Reduced 13.85%
21,993,732 $1.61 Billion
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $175 Million - $198 Million
2,261,603 Added 9.72%
25,530,146 $2.32 Billion
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $79 Million - $86.1 Million
-1,038,789 Reduced 4.27%
23,268,543 $1.96 Billion
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $1.67 Billion - $1.95 Billion
23,940,007 Added 6517.39%
24,307,332 $2.04 Billion
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $7.04 Million - $8.02 Million
101,113 Added 37.98%
367,325 $30.6 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $203,092 - $235,685
-3,113 Reduced 1.16%
266,212 $20.3 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $295,372 - $347,340
-5,120 Reduced 1.87%
269,325 $19.1 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $36,953 - $43,416
727 Added 0.27%
274,445 $16.7 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $600,308 - $697,729
-11,780 Reduced 4.13%
273,718 $14.9 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $27.8 Million - $33.2 Million
-538,138 Reduced 65.34%
285,498 $0
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $48.3 Million - $52 Million
823,636
823,636 $52.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.